Hindustan Unilever Limited Kwality Wall’s (India) Limited Equity Shares Approved for Listing and Trading

Hindustan Unilever Limited (HUL) announced that Kwality Wall’s (India) Limited (KWIL) has secured approval from both the BSE and NSE for the listing and trading of its equity shares. This follows the recently completed Scheme of Arrangement between HUL and KWIL. Trading commencement is scheduled for February 16, 2026, involving 2,34,95,91,262 equity shares.

Confirmation of Equity Share Listing for KWIL

Hindustan Unilever Limited (HUL) has formally informed the stock exchanges regarding the final regulatory step concerning the Scheme of Arrangement with Kwality Wall’s (India) Limited (KWIL). KWIL confirmed receipt of the necessary approvals from both the BSE Limited and National Stock Exchange of India Ltd (NSE) on February 12, 2026, for the listing and trading of its equity shares.

Key Details of the Listing

The approvals cover the listing of the entire equity base of KWIL following the corporate restructuring. The critical details provided by KWIL are:

  • Stock Exchanges: BSE and NSE
  • Security Type: Equity Shares, with a face value of ₹1/- each.
  • Total Number of Shares Listed: 2,34,95,91,262 equity shares.
  • Date of Approval: February 12, 2026.
  • Date of Commencement of Trading: Trading is set to commence effective February 16, 2026.

Stock Exchange Confirmations

Both exchanges confirmed the listing approval. The BSE letter, dated February 12, 2026, permitted the listing effective from February 16, 2026, under the relevant trading rules. The NSE similarly confirmed the listing and admission to dealings on the Exchange beginning February 16, 2026, covering distinctive numbers from 1 to 2,34,95,91,262 under the symbol KWIL.

HUL emphasized that this disclosure is made pursuant to ongoing requirements to keep the stock exchanges continuously informed about material information related to KWIL following the scheme’s implementation. Both parties confirm that all compliance requirements for post-listing obligations are being adhered to.

Source: BSE

Previous Article

Alkem Laboratories Ltd. Board Approves Q3 FY2026 Unaudited Results and Declares Interim Dividend

Next Article

Alkem Laboratories Amendment Approved for Saudi Arabia Joint Venture Equity Structure